Cargando…
Self-nanomicellizing solid dispersion of edaravone: part I – oral bioavailability improvement
BACKGROUND: Edaravone (EDR) is known for its free radical scavenging, antiapoptotic, antinecrotic, and anticytokine effects in neurological and non-neurological diseases. It is currently available clinically as Radicava(®) and Radicut(®), intravenous medications, recently approved for the treatment...
Autores principales: | Parikh, Ankit, Kathawala, Krishna, Tan, Chun Chuan, Garg, Sanjay, Zhou, Xin-Fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038876/ https://www.ncbi.nlm.nih.gov/pubmed/30013324 http://dx.doi.org/10.2147/DDDT.S161940 |
Ejemplares similares
-
Self-nanomicellizing solid dispersion of edaravone: part II: in vivo assessment of efficacy against behavior deficits and safety in Alzheimer’s disease model
por: Parikh, Ankit, et al.
Publicado: (2018) -
Lipid-based nanosystem of edaravone: development, optimization, characterization and in vitro/in vivo evaluation
por: Parikh, Ankit, et al.
Publicado: (2017) -
Novel self-nanomicellizing solid dispersion based on rebaudioside A: a potential nanoplatform for oral delivery of curcumin
por: Hou, Yuzhen, et al.
Publicado: (2019) -
Atorvastatin solid dispersion for bioavailability enhancement
por: Shamsuddin,, et al.
Publicado: (2016) -
Intranasal Delivery of Camptothecin-Loaded Tat-Modified Nanomicells for Treatment of Intracranial Brain Tumors
por: Taki, Hiroyuki, et al.
Publicado: (2012)